Gregory Renza

Stock Analyst at Truist Financial

(4.86)
# 380
Out of 5,136 analysts
885
Total ratings
52.1%
Success rate
18.7%
Average return

Stocks Rated by Gregory Renza

Perspective Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $11 → $8
Current: $0.9238
Upside: +765.99%
Agios Pharmaceuticals
Nov 6, 2026
Reiterated: Buy
Price Target: $37 → $35
Current: $30.15
Upside: +16.09%
Genmab
Nov 6, 2026
Reiterated: Buy
Price Target: $67
Current: $51.57
Upside: +29.92%
MannKind
Nov 6, 2026
Reiterated: Buy
Price Target: $5
Current: $3.96
Upside: +26.42%
BeOne Medicines AG
Nov 6, 2026
Reiterated: Buy
Price Target: $420 → $448
Current: $411.29
Upside: +8.93%
Amgen
Nov 4, 2026
Reiterated: Hold
Price Target: $380 → $398
Current: $462.32
Upside: -13.91%
IDEAYA Biosciences
Nov 3, 2026
Reiterated: Buy
Price Target: $57
Current: $30.36
Upside: +87.75%
Regeneron Pharmaceuticals
Nov 2, 2026
Reiterated: Buy
Price Target: $780 → $982
Current: $952.40
Upside: +3.11%
Exelixis
Oct 30, 2026
Reiterated: Hold
Price Target: $54 → $60
Current: $67.10
Upside: -10.58%
Gilead Sciences
Oct 30, 2026
Reiterated: Buy
Price Target: $158 → $181
Current: $167.58
Upside: +8.01%
Reiterated: Buy
Price Target: $34 → $35
Current: $26.45
Upside: +32.33%
Reiterated: Buy
Price Target: $29 → $40
Current: $35.40
Upside: +12.99%
Reiterated: Buy
Price Target: $240 → $241
Current: $166.87
Upside: +44.42%
Reiterated: Buy
Price Target: $34 → $33
Current: $14.73
Upside: +124.03%
Reiterated: Buy
Price Target: $286
Current: $239.77
Upside: +19.28%
Reiterated: Buy
Price Target: $87 → $85
Current: $26.80
Upside: +217.16%
Reiterated: Buy
Price Target: $155 → $151
Current: $83.61
Upside: +80.60%
Reiterated: Buy
Price Target: n/a
Current: $3.84
Upside: -
Reiterated: Buy
Price Target: n/a
Current: $84.78
Upside: -
Reiterated: Buy
Price Target: n/a
Current: $29.80
Upside: -
Reiterated: Buy
Price Target: n/a
Current: $13.29
Upside: -
Reiterated: Hold
Price Target: n/a
Current: $3.71
Upside: -
Reiterated: Hold
Price Target: $7
Current: $3.18
Upside: +120.13%
Reiterated: Buy
Price Target: $26
Current: $18.67
Upside: n/a
Reiterated: Buy
Price Target: $8
Current: $1.25
Upside: n/a
Reiterated: Hold
Price Target: $5
Current: $1.40
Upside: n/a
Reiterated: Hold
Price Target: $20
Current: $3.20
Upside: n/a
Reiterated: Buy
Price Target: $16
Current: $7.70
Upside: n/a
Reiterated: Buy
Price Target: $48 → $46
Current: $11.77
Upside: n/a
Reiterated: Hold
Price Target: $26
Current: $36.48
Upside: n/a
Reiterated: Buy
Price Target: $16
Current: $5.24
Upside: n/a
Reiterated: Buy
Price Target: $12 → $13
Current: $4.82
Upside: n/a
Reiterated: Hold
Price Target: $38
Current: $42.25
Upside: n/a
Downgraded: Hold
Price Target: $2,160 → $180
Current: $7.37
Upside: n/a
Reiterated: Hold
Price Target: $20.41
Current: $2.05
Upside: n/a
Reiterated: Hold
Price Target: $5 → $80
Current: $0.4063
Upside: n/a
Reiterated: Hold
Price Target: $1 → $15
Current: $0.000001
Upside: n/a
Rated: Buy
Price Target: $348
Current: $251.65
Upside: n/a